This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.
STARD13
Reaktivität: Human
ELISA, WB
Wirt: Kaninchen
Polyclonal
Biotin
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.32 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
STARD13
(StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
ARHGAP37 antikoerper, DLC2 antikoerper, GT650 antikoerper, LINC00464 antikoerper, RGD1564816 antikoerper, StAR related lipid transfer domain containing 13 antikoerper, StAR-related lipid transfer (START) domain containing 13 antikoerper, StAR-related lipid transfer domain containing 13 antikoerper, STARD13 antikoerper, Stard13 antikoerper
Hintergrund
This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.